PCA
TXG icon

Personal Capital Advisors’s 10x Genomics TXG Stock Holding History

Personal Capital Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-63,623
Closed -$9.48M – 555
2021
Q4 		$9.48M Hold
63,623
– – 0.04% 184
2021
Q3 		$9.26M Sell
63,623
-3,347
-5% -$575K 0.05% 177
2021
Q2 		$13.1M Sell
66,970
-137,215
-67% -$24.8M 0.07% 138
2021
Q1 		$37M Buy
204,185
+58,795
+40% +$10.2M 0.21% 110
2020
Q4 		$20.6M Buy
145,390
+123,495
+564% +$17.9M 0.13% 122
2020
Q3 		$2.73M Buy
+21,895
New +$2.3M 0.02% 218

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Personal Capital Advisors's TXG Position: Q1 2022 in Review

Personal Capital Advisors sold out of 10x Genomics (TXG) in Q1 2022, closing a stake of 63,623 shares — an estimated $9.48M sold.

Personal Capital Advisors first reported a position in TXG in Q3 2020 and held it in 6 quarters. The position peaked at $37M in Q1 2021. 314 funds tracked by Wall St. Rank hold TXG as of Q1 2022.

  • Personal Capital Advisors reported no remaining 10x Genomics position as of Q1 2022 after selling out during the quarter.
  • Personal Capital Advisors sold 63,623 10x Genomics shares in Q1 2022, an estimated $9.48M.
  • Personal Capital Advisors first reported a position in 10x Genomics in Q3 2020 and held it in 6 quarters.
  • Personal Capital Advisors's 10x Genomics position peaked at $37M in Q1 2021.
  • 314 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2022.

Based on Personal Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.